Some with lupus can safely go off medication, OMRF-led study finds January 30, 2024 Breakthrough could benefit people who take mycophenolate mofetil
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus.
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers.
